InvestorsHub Logo
Followers 10
Posts 469
Boards Moderated 0
Alias Born 08/02/2012

Re: 136 post# 411

Saturday, 06/29/2013 9:33:07 PM

Saturday, June 29, 2013 9:33:07 PM

Post# of 909
Yes, I'm sure if the studies showing the successful combo of daptomycin and tidezolid prove to be conclusive in vivo then Cubist will want to buy them out for sure. Maybe even sooner. Buyout or no buyout, I think TSRX will be a good investment.